Research and analysis

Topiramate: review of safety in pregnancy

Public Assessment Report of review of Topiramate safety data and expert advice on management of risks.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 20 June 2024

Documents

Topiramate: review of safety in pregnancy

PDF, 613 KB, 57 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents the review of safety data conducted by the MHRA in 2022/2023, the advice of the CHM and the implementation group in 2023 and 2024, and the steps that the MHRA are taking to implement the new safety measures.

Published 20 June 2024